Program
Donepezil
Also written as “Donepezil Hydrochloride”, “E2020” and “Donepezil TDS”.
Its studies are mostly in Alzheimer Disease · Down Syndrome · Lewy Body Disease · Cognitive Dysfunction · Dementia, led by 14 companies.
Drug pageDonepezil: every studyMany companies study it; this page follows only the 79 they lead. All 184 studies, academic ones too, with its approvals and label.Who develops it
Each company that leads studies of it, as its sponsor page counts them.
| Company | Studies it leads | Furthest phase | First study | Next primary completion |
|---|---|---|---|---|
| Eisai | 391 open or running | phase 4since Sep 12, 2005 | Nov 9, 2004 | May 6, 2030phase 1 · NCT07768592 |
| Pfizerits history only | 70 open or running | phase 4since Sep 9, 2005 | Sep 8, 2005 | none ahead |
| Coriumits history only | 60 open or running | phase 1since Nov 13, 2016 | Nov 13, 2016 | none ahead |
| Merckits history only | 50 open or running | phase 2since Feb 14, 2014 | Oct 21, 2008 | none ahead |
| Dr. Reddy's Laboratoriesits history only | 40 open or running | phase 1since Jan 3, 2012 | Jan 3, 2012 | none ahead |
| Teva Pharmaceutical Industriesits history only | 40 open or running | phase 1since Dec 14, 2010 | Dec 14, 2010 | none ahead |
| AstraZenecaits history only | 30 open or running | phase 1since Jul 9, 2008 | Jul 9, 2008 | none ahead |
| Icure Pharmaceuticalits history only | 30 open or running | phase 3since Jun 22, 2017 | May 15, 2013 | none ahead |
| GlaxoSmithKlineits history only | 20 open or running | phase 2since Jun 30, 2006 | Jun 30, 2006 | none ahead |
| Sun Pharmaceutical Industriesits history only | 20 open or running | phase 1since Jan 11, 2011 | Jan 11, 2011 | none ahead |
| AbbVieits history only | 10 open or running | phase 2since Aug 27, 2015 | Aug 27, 2015 | none ahead |
| Dongkook Pharmaceuticalits history only | 10 open or running | phase 1since Feb 18, 2016 | Feb 18, 2016 | none ahead |
| Teikoku Pharma USAits history only | 10 open or running | phase 2since Jun 5, 2009 | Jun 5, 2009 | none ahead |
| Theranexusits history only | 10 open or running | phase 1since Oct 2, 2018 | Oct 2, 2018 | none ahead |
Also a collaborator on its studies: PT Equilab International.
How these companies relate is not in the registry. A license or acquisition is shown only with a dated source, such as a company release or filing.
History and studies of Eisai only; the figures above count every company.
History and what’s ahead
From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.
Before these, 24 studies since Nov 9, 2004.
- May 14, 2009Phase 4 study in Cognitive DysfunctionNCT00934375 · 145 enrolled · United States
- Feb 1, 2010Phase 4 study in Kidney Failure, ChronicNCT01063556 · 6 enrolled · Japan
- Jan 12, 2011Phase 2 study in Alzheimer DiseaseNCT01276353 · 45 enrolled · Japan
- Jan 14, 2011Phase 3 study in Lewy Body DiseaseNCT01278407 · 142 enrolled · Japan
- Jul 26, 2011Phase 3 study in Alzheimer DiseaseNCT01404169 · 260 enrolled · China
- Jan 6, 20122 phase 1 studies in Healthy AdultNCT01506752, NCT01506739
- Feb 21, 2012Phase 3 study in Alzheimer DiseaseNCT01539031 · 351 enrolled · Japan
- Apr 25, 2013Phase 1 study in Healthy Elderly MaleNCT01843556 · 48 enrolled · Japan
- Jan 23, 2014Phase 1 study in Healthy SubjectsNCT02055703 · 195 enrolled · United States
- Mar 19, 2014Phase 2 study in Down SyndromeNCT02094053 · 36 enrolled · Japan
- Mar 24, 2014Phase 4 study in Alzheimer DiseaseNCT02097056 · 171 enrolled · Korea, Republic of
- Jan 19, 2015Phase 4 study in Lewy Body DiseaseNCT02345213 · 160 enrolled · Japan
- Jan 18, 2016Phase 4 study in Dementia Associated With Cerebrovascular DiseaseNCT02660983 · 302 enrolled · Korea, Republic of
- Aug 12, 2026Phase 1 study in Alzheimer DiseaseNCT07768592 · 32 planned
Ahead
- May 6, 2030Primary completion: phase 1 study in Alzheimer DiseaseNCT07768592
TargetBeta
“Acetylcholinesterase inhibitor”ChEMBL 37, by rule
Other programs on ACHE
| Program | Company | Furthest phase | Studies |
|---|---|---|---|
| huperzine Arule | wanbangde-pharmaceutical-group-co-ltd | phase 4 | 7 |
| benzgalantamine gluconaterule | alpha-cognition-inc | phase 4 | 1 |
| Z 338rule | Zeria Pharmaceutical | phase 3 | 12 |
Studies
All 39 Eisai leads, newest first. Each opens its study page.
| Study | Phase | Status | Primary completion | Size |
|---|---|---|---|---|
| NCT07768592Alzheimer Disease | 1 | Not yet recruiting | May 6, 2030 | 32 |
| NCT02660983Dementia Associated With Cerebrovascular Disease · Korea, Republic of | 4 | Completed | Jul 13, 2018 | 302 |
| NCT02345213Lewy Body Disease · Japan | 4 | Completed | May 15, 2017 | 160 |
| NCT02097056Alzheimer Disease · Korea, Republic of | 4 | Completed | May 2015 | 171 |
| NCT02094053Down Syndrome · Japan | 2 | Completed | Sep 16, 2016 | 36 |
| NCT02055703Healthy Subjects · United States | 1 | Completed | Apr 2014 | 195 |
| NCT01843556Healthy Elderly Male · Japan | 1 | Completed | Apr 2013 | 48 |
| NCT01539031Alzheimer Disease · Japan | 3 | Completed | Jan 2015 | 351 |
| NCT01506752Healthy Adult · Japan | 1 | Completed | Sep 2011 | 20 |
| NCT01506739Healthy Adult · Japan | 1 | Completed | May 2011 | 12 |
| NCT01404169Alzheimer Disease · China | 3 | Completed | Jul 2014 | 260 |
| NCT01278407Lewy Body Disease · Japan | 3 | Completed | Mar 2013 | 142 |
| NCT01276353Alzheimer Disease · Japan | 2 | Completed | Apr 2012 | 45 |
| NCT01063556Kidney Failure, Chronic · Japan | 4 | Completed | Mar 2010 | 6 |
| NCT00934375Cognitive Dysfunction · United States | 4 | Completed | Sep 2007 | 145 |
| NCT01146509Migraine Disorders · United States | 2 | Completed | Apr 2004 | 89 |
| NCT00754052Down Syndrome · United States | 3 | Terminated | Nov 2008 | 8 |
| NCT00754013Down Syndrome · United States | 3 | Terminated | Oct 2008 | 9 |
| NCT00688376Neoplasms · United States, Argentina, Australia and more | 3 | Completed | May 26, 2009 | 72 |
| NCT00675025Down Syndrome · United States | 2 | Terminated | Nov 13, 2008 | 117 |
| NCT00711204Alzheimer Disease · United States | 4 | Withdrawn | Jun 2009 | 0 |
| NCT00598650Lewy Body Disease | 2 | Completed | Mar 2011 | 160 |
| NCT00571064Mild to Severe Alzheimer's Disease · United States | 4 | Completed | Dec 2008 | 97 |
| NCT00570128Down Syndrome · United States | 2 | Completed | Sep 5, 2008 | 129 |
| NCT00566501Alzheimer Disease · United States | 3 | Completed | Apr 1, 2010 | 915 |
| NCT00543855Lewy Body Disease · Japan | 2 | Completed | Feb 2010 | 167 |
| NCT00477659Alzheimer Disease · United States | 4 | Completed | Aug 15, 2008 | 14 |
| NCT00478205Alzheimer Disease · United States | 3 | Completed | Jun 2009 | 1,467 |
| NCT00381381Alzheimer Disease · Korea, Republic of | 4 | Completed | Aug 31, 2008 | 199 |
| NCT00293176Memory Disorders · United States | 4 | Completed | Mar 2007 | 821 |
| NCT00230568Alzheimer Disease · United States | 4 | Completed | Apr 2007 | 100 |
| NCT00165815Dementia With Parkinson's Disease · Germany, Ireland | 3 | Completed | ||
| NCT00165763Dementia, Vascular · Philippines | 4 | Completed | Sep 2009 | 36 |
| NCT00165750Alzheimer Disease · Korea, Republic of | 4 | Terminated | Aug 2008 | 40 |
| NCT00165737Dementia, Vascular · United States | 3 | Completed | Aug 2005 | 974 |
| NCT00165724Alzheimer Disease · Korea, Republic of | 4 | Completed | Jul 31, 2006 | 114 |
| NCT00165659Alzheimer Disease · Japan | 2 | Completed | May 2005 | |
| NCT00103948Cognitive Dysfunction · United States, Australia, Spain | 2 | Completed | Oct 2006 | 165 |
| NCT00096473Alzheimer Disease · United States, Australia, Canada and more | 3 | Completed | Jun 2005 | 229 |
How it is read
Names in the registry
- “Donepezil”, 26 entries
- “Donepezil Hydrochloride”, 14 entries
- “E2020”, 7 entries
- “Donepezil TDS”, 5 entries
- “Donepezil hydrochloride”, 5 entries
Conditions, from the studies’ own filings
- Alzheimer Disease, 38 studies
- Down Syndrome, 5 studies
- Lewy Body Disease, 4 studies
- Cognitive Dysfunction, 3 studies
- Dementia, 3 studies
First seen by our ledger Nov 13, 2026.
What this can’t show
- Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
- Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
- Primary completion dates are the sponsors’ estimates and often move.
- A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.